Co-GP / Platform:A family office could deploy into the Greater Boston life science market by backing a sponsor or operator at the GP level, sharing in the promote and benefiting from a robust pipeline.

Co-GP / Platform:A family office could deploy into the Boston life sciences market by backing a sponsor/operator at the GP level to share in the promote and access a repeatable pipeline of projects.

Co-GP / Platform:A family office could deploy into the San Francisco Bay Area life sciences market by backing a sponsor/operator at the GP level to share in the promote and access a pipeline of opportunities.

Co-GP / Platform:A family office could deploy into the San Diego life sciences market by backing a sponsor/operator at the GP level, focusing on those with a proven track record in managing life science assets.

Co-GP / Platform:A family office could deploy into the life sciences market by partnering with established operators to co-GP on projects that leverage academic and medical partnerships.

Co-GP / Platform:A family office could deploy into the UK Golden Triangle life sciences market by backing a sponsor or operator at the GP level, focusing on co-GP or JV equity structures to share in the promote.

Co-GP / Platform:A family office could deploy into the life sciences market by backing a specialized operator at the GP level, sharing in the promote and benefiting from a robust pipeline.

Co-GP / Platform:A family office could deploy into the Raleigh life sciences market by backing a sponsor or operator at the GP level, sharing in the promote and benefiting from their expertise.

Co-GP / Platform:A family office could deploy into the Boston life sciences market by backing a sponsor or operator at the GP level, sharing in the promote and benefiting from their expertise.

Co-GP / Platform:A family office could deploy into this market by backing a sponsor/operator focused on developing biotech incubators or educational partnerships to share in the promote and enterprise value.

Co-GP / Platform:A family office could deploy into the Greater Boston life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.

Co-GP / Platform:A family office could deploy into the New York City life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from a robust pipeline.

Co-GP / Platform:A family office could deploy into this market by backing a life sciences operator at the GP level, sharing in the promote and benefiting from the sector's growth.

Co-GP / Platform:A family office could deploy into the New York life sciences market by backing a sponsor/operator involved in the development of new facilities or technologies, sharing in the promote and aligning interests.

Co-GP / Platform:A family office could deploy into the Seattle life sciences market by backing a sponsor/operator at the GP level, sharing in the promote and accessing a pipeline of development projects.

Co-GP / Platform:A family office could deploy into the San Francisco life sciences market by backing a sponsor or operator at the GP level, particularly those involved in the recent leasing activity and development projects.

Co-GP / Platform:A family office could deploy into the San Diego life science market by backing a sponsor/operator at the GP level to share in the promote and access a pipeline of opportunities.

Co-GP / Platform:A family office could deploy into this market by backing a sponsor/operator at the GP level, particularly in light of Amgen's $1.0 billion expansion and other major developments.

Co-GP / Platform:A family office could deploy into this market by backing a life sciences operator at the GP level, sharing in the promote and benefiting from a strong pipeline of projects.

Co-GP / Platform:A family office could deploy into the Boston-Cambridge life sciences market by backing a sponsor/operator at the GP level, sharing in the promote and accessing a pipeline of development projects.

Co-GP / Platform:A family office could deploy into this market by backing a life sciences operator at the GP level, participating in co-GP or JV equity to share in the promote and benefit from the sector's growth.

Co-GP / Platform:A family office could deploy into the life sciences market by backing a sponsor that specializes in developing tailored lab spaces, sharing in the promote and enterprise value.

Co-GP / Platform:A family office could deploy into the San Diego life sciences market by partnering with operators like Trammell Crow or Stockdale Capital Partners at the GP level to share in the promote and benefit from their development pipelines.

Co-GP / Platform:A family office could deploy into this market by backing developers of major projects like The Silverman Group or Vision Real Estate Partners at the GP level to share in the promote from significant developments.